Eef Schimmelpennink is the founder of LENZ Therapeutics. LENZ Therapeutics has raised $47M in total funding. Latest round: Series A.
Eef Schimmelpennink is the President and CEO of LENZ Therapeutics, a late clinical-stage biopharmaceutical company. He led the company out of stealth mode in 2021 with a $47 million Series A financing and oversaw its merger with Graphite Bio in March 2024, leading to the company becoming publicly traded.
Full founder directory · Investor directory · Company funding database · Fundraising library